ALAI - ATI | QuestionPro

ACCOUNT MANAGER NAME

ACCOUNT

Has this account changed their management approach to the APS/ALAI category in the last 12 months? (SELECT ANY THAT APPLY

MANAGEMENT OBJECTIVES: The plan has expressed their current management objectives for the antipsychotic oral and LAI I market as: (SELECT ANY THAT APPLY)

Is the account likely to change their management approach in the APS/ALAI category in the next 12 months? (SELECT ANY THAT APPLY)

For a newly approved drug, in a protected class, what type of coverage will be assigned prior to a P&T review and a formulary action? (ALL THAT APPLY)

Not covered (NDC block)

Covered with Non-preferred Tier status

Covered after Step therapy with formulary listed products

Covered after Prior Authorization or medical exception

For a newly approved drug, in a protected class, are they likely to conduct a review for the individual product or the entire category?

Individual product review

Category review

Don’t know

For a newly approved drug, in a protected class, when will are they likely to conduct a review for the category/product?

	Medicare	Medicaid	Commercial
Est. Review Month (MM/YY)

For a newly approved drug, in a protected class, when will are they likely to conduct a review for the category/product? (Please select the approximate month)

Please select the option which best characterizes any unsolicited comments the customer has volunteered related to the importance of the category to in terms of their priorities.